Treatment with botulinum toxin type A (BTX-A) is a well-established option in the management of spasticity, providing focal reductions in muscle tone in Cerebral Palsy patients. Many medical studies have demonstrated the effectiveness of BTX-A injections in reducing muscle tone, increasing the range of motion, and improving posture and gait in Cerebral Palsy patients.
